Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer

A modified FASP protocol for high-throughput preparation of protein samples for mass spectrometry

(2017) Jeremy Potriquet et al.   PLoS One

Parasite Infection, Carcinogenesis and Human Malignancy

(2017) Hoang van Tong et al.   EBioMedicine

Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment

(2016) James R. Kintzing et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis

(2016) Bajin Wei et al.   OncoTargets and Therapy

Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?

(2016) S Baig et al.   Cell Death & Disease

Tentacle Transcriptome and Venom Proteome of the Pacific Sea Nettle, Chrysaora fuscescens (Cnidaria: Scyphozoa)

(2016) Dalia Ponce et al.   Toxins

Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy

(2016) Sandhya Srikanth et al.   Frontiers in Pharmacology

PEGylation in anti-cancer therapy: An overview

(2016) Prajna Mishra et al.   Asian Journal of Pharmaceutical Sciences

Building high-quality assay libraries for targeted analysis of SWATH MS data

(2015) Olga T Schubert et al.   Nature Protocols

Cloning and Characterization of Two Potent Kunitz Type Protease Inhibitors from Echinococcus granulosus

(2015) Shiwanthi L. Ranasinghe et al.   PLoS Neglected Tropical Diseases

Neutrophils in Cancer: Two Sides of the Same Coin

(2015) Eileen Uribe-Querol et al.   Journal of Immunology Research

Sorting and identification of side population cells in the human cervical cancer cell line HeLa

(2014) Wenjuan Qi et al.   Cancer Cell International

Ki67 is a promising molecular target in the diagnosis of cancer (Review)

(2014) LIAN TAO LI et al.   Molecular Medicine Reports

Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models

(2014) Glen M. Boyle et al.   PLoS One

Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer

(2013) Paul Toomey et al.   PLoS One

The Future of Peptide-based Drugs

(2012) David J. Craik et al.   Chemical Biology & Drug Design

Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis

(2012) Ludovic C. Gillet et al.   MOLECULAR & CELLULAR PROTEOMICS

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

Mitosis-targeted anti-cancer therapies: where they stand

(2012) K-S Chan et al.   Cell Death & Disease

Tumor-Associated Neutrophils: New Targets for Cancer Therapy

(2011) A. D. Gregory et al.   CANCER RESEARCH

Scabies Mite Inactivated Serine Protease Paralogs Inhibit the Human Complement System

(2009) F. C. Bergstrom et al.   JOURNAL OF IMMUNOLOGY

Helminth immunoregulation: The role of parasite secreted proteins in modulating host immunity

(2009) James P. Hewitson et al.   MOLECULAR AND BIOCHEMICAL PARASITOLOGY

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

(2009) M. M. Schmidt et al.   MOLECULAR CANCER THERAPEUTICS

A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells

(2008) Vanessa D. Atayde et al.   MELANOMA RESEARCH